🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Bevacizumab plus capecitabin is a standard maintenance treatment following ...
Status
Withdrawn
Location
Rongbo Lin
Start Date
2018-11
Trial ID
NCT03708536
Treatments Being Tested
In initially metastatic rectal carcinoma, a neo-adjuvant multi-drug chemoth...
Status
Terminated
Location
Institut de Cancérologie de l'Ouest
Start Date
2015-05-05
Trial ID
NCT03634202
Treatments Being Tested
This is a randomized, open-label, multicenter phase III trial of ramuciruma...
Status
Unknown
Location
Maria Di Bartolomeo
Start Date
2016-12
Trial ID
NCT02934464
Treatments Being Tested
A randomized, multicenter, Phase I/IIa clinical study to evaluate the toler...
Status
Unknown
Location
Affiliated Hospital of Academy of Military Medical Sciences
Start Date
2014-03-28
Trial ID
NCT04170595
This is a phase Ib/II, open-label, multicenter study to evaluate the safety...
Status
Completed
Location
Shanghai East Hospital
Start Date
2023-12-06
Trial ID
NCT06139211
As an established therapeutic target, HER2 is widely used in a variety of t...
Status
Unknown
Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Start Date
2023-07-18
Trial ID
NCT05578287
Treatments Being Tested
This is a single-armed, multicenter, non-blinded phase 2 study to assess ef...
Status
Active Not Recruiting
Location
Antoni van Leeuwenhoek ziekenhuis
Start Date
2022-03-14
Trial ID
NCT05200988
Treatments Being Tested
The main purpose of this study is to evaluate safety, tolerability and the ...
Status
Unknown
Location
Beijing cancer hospical
Start Date
2023-06-21
Trial ID
NCT05964543
Treatments Being Tested
Squamous cell carcinoma of the anus is still a rare disease but its inciden...
Status
Recruiting
Location
AGEN-Cromg
Start Date
2024-02-26
Trial ID
NCT06207981
The intensity of tumour response appears to be correlated with the feasibil...
Status
Terminated
Location
Hopital Pierre Oudot - Service de Gastroenterologie
Start Date
2016-09
Trial ID
NCT02842580
Treatments Being Tested